Daily Management Review

Pfizer & Merck’s Joint Venture In Diabetes Drug Gets EMA Committee’s Recommendation


01/27/2018


Steglatro will be treating type II diabetes orally.



One panel of European Medicines Agency, shortly called EMA, has come up with a recommendation of “granting marketing approval” towards a drug for diabetes that has been jointly developed by Merck & Co and Pfizer Inc.
 
The said recommendation of the EMA panel for “Medicinal Products for Human Use” can be a booster to the European Commission bound companies. The drug, an oral treatment used for treating “Type II diabetes”, will be coming to the market under the name of Steglatro.
 
Steglatro is a “SGLT2 inhibitors” which will help the patients’ “excess glucose” to be expelled “through urine”. While Reuters added:
“In December, Merck and Pfizer won approval from the U.S. Food and Drug Administration for Steglatro as a single therapy and in fixed-dose combinations with Merck’s diabetes drug Januvia or with metformin, an older generic treatment typically given to newly diagnosed patients”.
 
Diabetes can cause severe organ damage affecting the “eyes and kidneys” besides it can also raise significant risk of “heart attack and stroke”. With the progression of “type II diabetes” many patients require “additional treatments” to keep their “blood sugar levels” under “better control”.
References:
reuters.com







Science & Technology

Europe overtakes US by number of patents for self-driving car technologies

Samsung introduces display technology for folding screens

How retailers use technologies to increase sales

Facebook releases videochat devices Portal and Portal Plus

Smartphone makers will pay for pre-installing Google apps‍

Five loudest data leaks

Airbus announces Moon exploration competition

Former Head Of Google China Thinks Funding In AI Should Be Doubled By US

Germany Introduces The First Ever Train To Run On 100% Hydrogen

Germany Plans On Cyber Security Research To End Reliance On U.S. Tech

World Politics

World & Politics

Brexit Negotiators Of Both Parties Close Down On Irish Border Text, Reports RTE

Bloomberg: Theresa May can face catastrophic defeat in parliament

New Asian Foreign Policy May Be Set By Congress After Democrats Taking Control Of House

Italy refuses to change draft budget

Italy is about to tighten its migration policy

Macron calls to create a pan-European army

Signals Of Mending Of US-China Emerge Before Anticipated G20 Meet

Moscovici: the European Commission may impose sanctions on Italy